Literature DB >> 8333497

Inhibitory effect of EGF on secretory response of rat parietal cells is associated with an induction of ODC.

J Ostrowski1, K Wojciechowski, S J Konturek, E Butruk.   

Abstract

The present studies were designed to evaluate the parietal cell acid production in response to short-time stimulation by epidermal growth factor (EGF). Studies were performed in vitro using isolated cells from rat stomachs, and acid production was indirectly determined by [14C]aminopyrine accumulation. EGF inhibited histamine-stimulated aminopyrine accumulation from standard incubation medium (K+ = 5 mM) but not from that with increased K+ concentration (K+ = 70 mM). EGF significantly stimulated ornithine decarboxylase (ODC) activity, an effect that was blocked by the specific ODC inhibitor, difluoromethylornithine (DFMO). In the presence of DFMO, EGF failed to inhibit histamine-stimulated aminopyrine uptake. Like EGF, the polyamine spermine, which is a direct product of enhanced ODC activity, also inhibited histamine-stimulated aminopyrine uptake. Unlike EGF, the spermine-induced inhibition of aminopyrine accumulation was not altered by DFMO. Thus the DFMO effect was specific to EGF. Taken together, these results are consistent with the postulate that EGF inhibits parietal cell secretory response through the induction of ODC activity and increased synthesis of polyamines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333497     DOI: 10.1152/ajpcell.1993.264.6.C1428

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Immunohistochemical analysis of EGF-R in gastric mucosa in portal hypertensive with cirrhosis.

Authors:  Z Yang
Journal:  J Tongji Med Univ       Date:  1997

2.  Increased activity of MAP, p70S6 and p90rs kinases is associated with AP-1 activation in spontaneous liver tumours, but not in adjacent tissue in mice.

Authors:  J Ostrowski; M Woszczynski; P Kowalczyk; T Wocial; E Hennig; L Trzeciak; P Janik; K Bomsztyk
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.